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Although history ofmedicine is no longer
devoted exclusively to great men and their
research, they are still worth studying under
certain circumstances, above all ifthey
represent important scientific research
strands and movements of their times. This
is certainly true for the immunologist and
bacteriologist Paul Ehrlich (1854-1915),
whose work had an impact on several areas
within twentieth-century biomedicine.
Arthur Silverstein's book deals with one
of the most important aspects of Ehrlich's
work, namely his research in immunology,
and describes and analyses the development
of Ehrlich's "side-chain" or "receptor
theory". Ehrlich promoted the application
ofchemistry in medicine and used tissue
staining to analyse the chemical binding of
substances to morphological structures,
especially cells. He applied this work to the
investigation ofimmunological problems.
Antigens (or toxins) bind with specific
"side-chains" of cells to unfold their effects.
As many side-chains are bound by antigens,
the cell "overcompensates" when releasing a
large quantity of side-chains into the blood-
stream. These side-chains function as
antibodies able to bind antigens and to
avoid further infection. In 1900, the side-
chains were renamed "receptors". Ehrlich
applied his theory to research on both
cancer and chemotherapy, leading to his
development of the famous substance
Salvarsan for the treatment of syphilis in
1910.
The strength of Silverstein's work lies in
the medical detail of this important story.
He offers interesting insights into the
receptor theory's development and defence.
For example, he explains Ehrlich's
experiments in the field of paediatric
immunology, and gives an interesting
account of the debate between Ehrlich and
Jules Bordet (1870-1961) of the Pasteur
Institute in Paris. In discussing the views of
Ehrlich's critics, Silverstein also analyses his
explanation of the side-chain or receptor
theory and looks at how immunologists
received it.
Although this is without doubt one of the
book's merits, it also carries a basic
methodological problem. Silverstein writes
mainly from the perspective of the
immunologist. He describes the path from
staining to side-chains as a success story
rooted in the genius of the "imaginative
Paul Ehrlich" (p. 12). It is a history of
ideas, describing the receptor concept as the
logical outcome of Ehrlich's productive
genius. Ofcourse, logical sequence can be
detected in Ehrlich's immunological
investigations but it is important to consider
that the realization of a new scientific
concept depends not least on the specific
circumstances of the scientist's social and
academic life. Silverstein mentions the
breaks and troubles in Ehrlich's life only
randomly, although the end ofEhrlich's
clinical career as well as his need as a Jew
to get a safe position in the German
university system were seemingly influential
in changing his research interests and
enabling him to make his intricate
investigations on the side-chain and
receptor theory. These shortcomings are
surprising since Silverstein himselfhints at
such socio-historical perspectives, for
example: "It was only the direct request of
Behring ... that would allow Ehrlich to
venture into an area to which his institute
colleague had full priority claim"
(immunological research on diphtheria,
p. 42). Moreover, Silverstein's contribution
is presentist. Even in the early stage of
Ehrlich's career, he searches for "receptors"
using the term when dealing with papers
written before 1900.
The book presents no new general
interpretative approach to Ehrlich's
immunology, and it does not reach beyond
the splendid article on Ehrlich written by
Claude Dolman in the Dictionary of
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Scientific Biography in 1989. Nevertheless, it
is an important contribution. As the time is
not yet ripe for a detailed biography, we
need books on single aspects of Ehrlich's
life. His papers, held at the Rockefeller
Archive Center in New York, contain a lot
of material that needs to be considered.
Thus, in spite of its shortcomings,
Silverstein's book is important as it gives a
rich and detailed overview of the intellectual
development of Ehrlich's immunology.
Cay-Rudiger PrOiil,
Wolfson Research Institute,
University of Durham,
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Florence S Mahoney, a wealthy private
citizen, assisted the growth of the
biomedical research enterprise in the United
States federal-government during the last six
decades of the twentieth century. Mahoney
exuded intelligence and charm; and she had
access to leaders in politics (especially in the
Democratic Party) and newspaper
publishing.
Mahoney and Mary Lasker, her principal
ally, began to lobby for public investment in
biomedical research during the 1940s. In
that decade, an ever-growing number of
opinion leaders believed that increased
public spending for research, professional
education, and facilities would quickly
translate into longer and more pleasant lives
for Americans.
Two new federal policies financed what
became a supply side spending spree on
behalf of the health sector that continues
today. Robinson relegates one of these
policy innovations, establishing the
extramural research programme of the
National Institutes of Health, to a footnote
and does not mention the other, massive
federal subsidies to build and equip
hospitals.
Congress routinely re-authorized the US
Public Health Service (PHS), which includes
the NIH, while the Second World War was
the highest national priority. As a result,
few people except agency and Congressional
staff noticed that the PHS now had
authority to make grants for research to
non-federal investigators and institutions. In
the final months of the war, PHS leaders
quietly secured White House approval to
transfer the most promising research
contracts, as well as funding to continue
them, from the temporary federal agency
that managed wartime science to the new
NIH extramural grants programme. Within
a few weeks these contracts became the first
NIH grants.
Meanwhile, a highly visible effort to
establish, through legislation, a national
agency to fund research in all scientific
fields stalled because of conflicts about
policy within Congress and between
Congress and the White House. These
conflicts were not resolved for almost five
years, during which NIH leaders and their
allies, who included leaders in research,
advocacy and philanthropic groups, and the
media, as well as Mahoney and Lasker,
took advantage of the absence of
competition. When the National Science
Foundation began to operate in 1950,
biomedical research remained the
responsibility of the NIH.
Robinson relegates this well-documented
history to a footnote (p. 284). Perhaps she
did so to reinforce her claim that "Mahoney
and Lasker [were] skeptical that existing
agencies like the PHS were up to the job
that the women had in mind" (p. 71) and
her implication that, eventually, PHS did
her heroines' bidding. But with the
exception of the creation of a new National
Institute for Mental Health, when Mahoney
and Lasker led a coalition, PHS leaders and
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